{
    "clinical_study": {
        "@rank": "120895", 
        "arm_group": [
            {
                "arm_group_label": "Early Vitamin E", 
                "arm_group_type": "Experimental", 
                "description": "Vitamin E is administered from Days 1-15 after the initial excision surgery after admission."
            }, 
            {
                "arm_group_label": "Delayed Vitamin E", 
                "arm_group_type": "Experimental", 
                "description": "Vitamin E is administered from Days 16-30 after the initial excision surgery after admission."
            }
        ], 
        "brief_summary": {
            "textblock": "A dietary antioxidant, alpha-tocopherol, will be used to potentially attenuate Vitamin E\n      short- and long-term losses in plasma and adipose, reverse the oxidative stress of burn\n      injury and, in the process, decrease the secondary consequences of burn injury, including\n      lung injury and impaired wound healing.  This may improve the quality of life of the burn\n      patient by preventing pathophysiology that may result from oxidative stress and may reduce\n      hospital stay. Our research will lay the foundation for the future development of effective,\n      safe, and economic therapeutic interventions to treat burn injury-associated metabolic\n      abnormalities.  Also, it will provide the basis for the development of supplemental\n      regulations and pharmacotherapy to treat burn patients with vitamin E.  The risks are very\n      reasonable in relation to the anticipated benefits to our subjects because a) vitamin E is a\n      simple vitamin that is abundant and approved for clinical use, and b) the subjects will be\n      monitored consistently for the minimal increased tendency to bleed."
        }, 
        "brief_title": "Vitamin E Supplementation in Burned Patients", 
        "condition": "Burn", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age: 16 - 85 years\n\n          -  \u226540% total body surface area burn\n\n        Exclusion Criteria:\n\n          -  Septic shock\n\n          -  Bleeding disorders\n\n          -  Diabetes, or on diabetes medications or anti-lipidemic agents\n\n          -  Arthritis\n\n          -  Known kidney/renal disease, endocrine disease, cancer, heart disease, osteoporosis,\n             liver disease\n\n          -  Congestive heart failure\n\n          -  Positive hepatitis or HIV screens\n\n          -  Pregnancy (women)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "42", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01749371", 
            "org_study_id": "12-189"
        }, 
        "intervention": {
            "arm_group_label": [
                "Early Vitamin E", 
                "Delayed Vitamin E"
            ], 
            "intervention_name": "Vitamin E (dl-Alpha Tocopheryl)", 
            "intervention_type": "Drug", 
            "other_name": [
                "Vitamin E", 
                "dl-Alpha Tocopheryl", 
                "Alpha Tocopherol", 
                "Aqueous Vitamin E Oral Drops"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin E", 
                "Alpha-Tocopherol", 
                "Tocopherols", 
                "Tocotrienols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Alpha-Tocopherol", 
            "Gamma-Tocopherol", 
            "Inflammation", 
            "Oxidative Stress", 
            "Malondialdehyde", 
            "Isoprostanes", 
            "Lung Dysfunction", 
            "Wound Healing"
        ], 
        "lastchanged_date": "February 20, 2013", 
        "location": [
            {
                "contact": {
                    "email": "steven.wolf@utsouthwestern.edu", 
                    "last_name": "Steven E Wolf, MD", 
                    "phone": "214-648-2041"
                }, 
                "contact_backup": {
                    "email": "agnes.burris@utsouthwestern.edu", 
                    "last_name": "Agnes Burris, RN", 
                    "phone": "2146483521"
                }, 
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75390"
                    }, 
                    "name": "University of Texas Southwestern Medical Center, Parkland Health and Hospital System"
                }, 
                "investigator": [
                    {
                        "last_name": "Steven Wolf, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "John Hunt, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Brett Arnoldo, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "peenkhba@utmb.edu", 
                    "last_name": "Perenlei Enkhbaatar, MD, PhD", 
                    "phone": "409-747-0096"
                }, 
                "contact_backup": {
                    "email": "lesousse@utmb.edu", 
                    "last_name": "Linda E Sousse, PhD, MBA", 
                    "phone": "3617285536"
                }, 
                "facility": {
                    "address": {
                        "city": "Galveston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77555"
                    }, 
                    "name": "University of Texas Medical Branch: Blocker Burn Unit and Shriners Hospitals for Children"
                }, 
                "investigator": [
                    {
                        "last_name": "Perenlei Enkhbaatar, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Hal K Hawkins, MD, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jong O Lee, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Linda E Sousse, PhD, MBA", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "David N Herndon, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Kristofer Jennings, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Celeste C Finnerty, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Ronald P Mlcak, PhD, MBA", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "James.M.Cross@uth.tmc.edu", 
                    "last_name": "James M Cross, MD", 
                    "phone": "713-500-6407"
                }, 
                "contact_backup": {
                    "email": "Jeanette.M.Podbielski@uth.tmc.edu", 
                    "last_name": "Jeanette M Podbielski, RN", 
                    "phone": "7135006407"
                }, 
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Memorial Hermann Hospital Burn Intensive Care Unit"
                }, 
                "investigator": [
                    {
                        "last_name": "James M Cross, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Todd Huzar, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Charles Wade, PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Vitamin E Supplementation in Burned Patients", 
        "overall_contact": {
            "email": "lesousse@utmb.edu", 
            "last_name": "Linda E Sousse, PhD, MBA", 
            "phone": "3617285536"
        }, 
        "overall_contact_backup": {
            "email": "peenkhba@utmb.edu", 
            "last_name": "Perenlei Enkhbaatar, MD, PhD", 
            "phone": "4097470096"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Texas", 
                "last_name": "Perenlei Enkhbaatar, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Texas", 
                "last_name": "Linda E Sousse, PhD, MBA", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Federal Government"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Plasma Alpha- and Gamma-Tocopherol", 
            "safety_issue": "Yes", 
            "time_frame": "Days 0-30"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01749371"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Pulmonary Function Testing", 
                "safety_issue": "No", 
                "time_frame": "Day 30"
            }, 
            {
                "measure": "Exercise Stress Test", 
                "safety_issue": "No", 
                "time_frame": "Day 30"
            }, 
            {
                "measure": "Wound Healing", 
                "safety_issue": "No", 
                "time_frame": "Days 0-30"
            }, 
            {
                "measure": "Plasma and Urine Malondialdehyde, Isoprostanes, Vitamin E Metabolites", 
                "safety_issue": "No", 
                "time_frame": "Days 0-30"
            }, 
            {
                "measure": "Adipose Alpha- and Gamma-Tocopherol", 
                "safety_issue": "No", 
                "time_frame": "Days 0-30"
            }
        ], 
        "source": "The University of Texas, Galveston", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Shriners Hospitals for Children", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Memorial Hermann Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Texas", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "The University of Texas, Galveston", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}